Similar articles

• [Reinventing thalidomide under high supervision].

  Monneret C. Monneret C. Ann Pharm Fr. 2010 May;68(3):133-5. doi: 10.1016/j.pharma.2010.05.001. Ann Pharm Fr. 2010. PMID: 20569769 French. No abstract available.
• [On the history of the Contergan (thalidomide) catastrophe in the light of drug legislation].

  Maio G. Maio G. Dtsch Med Wochenschr. 2001 Oct 19;126(42):1183-6. doi: 10.1055/s-2001-17888. Dtsch Med Wochenschr. 2001. PMID: 11607860 German. No abstract available.
• [The Contergan (Thalidomide) case. Catastrophic consequences].

  Schulte-Wissermann H. Schulte-Wissermann H. Kinderkrankenschwester. 2000 Sep;19(9):360-6. Kinderkrankenschwester. 2000. PMID: 11061148 German. No abstract available.
• Critical periods of prenatal toxic insults.

  Goldman AS. Goldman AS. Prog Clin Biol Res. 1980;36:9-31. Prog Clin Biol Res. 1980. PMID: 6995988 Review. No abstract available.
• [The thalidomide story and its lessons].

  Dolev E. Dolev E. Harefuah. 2001 Jul;140(7):663-7. Harefuah. 2001. PMID: 11481978 Review. Hebrew. No abstract available.